Overview
Maximizing Patient-Case Manager Communication and Collaboration for ACS Patients: Meeting ACO Performance Targets
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
This webinar addresses provider adherence to ACS guidelines, patient education, and discharge and transition strategies between hospital and home in an effort to reduce hospital readmission. Our cardiologist and pharmacist faculty discuss methodologies to reduce readmission rates among ACS patients. Downloadable resources are available for case managers to employ within their practice or share with patients.
It is estimated that 1 in 5 Medicare patients discharged from a hospital will be readmitted within 30 days, and that 67% of patients surviving a coronary event will suffer a recurrent event requiring rehospitalization. The Medicare Hospital Readmissions Reduction Program is part of the Affordable Care Act and provides a financial incentive to hospitals to lower patient readmission rates but does not provide clear guidance on how to reduce readmissions.
It is estimated that 1 in 5 Medicare patients discharged from a hospital will be readmitted within 30 days, and that 67% of patients surviving a coronary event will suffer a recurrent event requiring rehospitalization. The Medicare Hospital Readmissions Reduction Program is part of the Affordable Care Act and provides a financial incentive to hospitals to lower patient readmission rates but does not provide clear guidance on how to reduce readmissions.
This activity is designed for case managers, along with physicians, nurses and hospital pharmacists, who are responsible for meeting accountable care organization (ACO) performance targets when overseeing patients with acute coronary syndrome (ACS).
It is estimated that 1 in 5 Medicare patients discharged from a hospital will be readmitted within 30 days, and that 67% of patients surviving a coronary event will suffer a recurrent event requiring rehospitalization. The Medicare Hospital Readmissions Reduction Program is part of the Affordable Care Act and provides a financial incentive to hospitals to lower patient readmission rates but does not provide clear guidance on how to reduce readmissions. This activity addresses provider adherence to ACS guidelines, patient education, and discharge and transition strategies between hospital and home in an effort to reduce hospital readmission. Through this webcast, our cardiologist and pharmacist faculty discuss methodologies to reduce readmission rates among ACS patients. Downloadable resources are available for case managers to employ within their practice or share with patients.
Upon completion of this activity, participants will be able to:
For physicians, pharmacists:
• Discuss clinical guidelines for the use of antiplatelet therapies in patients with ACS who are hospitalized, undergoing percutaneous coronary intervention, or being discharged with maintenance therapy
• Compare and contrast the efficacy and safety of antiplatelet therapies and their use in diverse ACS patients
• Formulate strategies to facilitate transitions of care, improve discharge communication, ensure patient adherence, and reduce complications and hospital readmissions related to ACS
For nurses, case managers:
• Review clinical guidelines for the use of antiplatelet therapies in patients with ACS who are hospitalized, undergoing percutaneous coronary intervention, or being discharged with maintenance therapy
• Explain why specific antiplatelet therapies are selected for specific ACS patient subsets
• Formulate strategies to facilitate transitions of care, improve discharge communication, ensure patient adherence, and reduce complications and hospital readmissions related to ACS
For physicians, pharmacists:
• Discuss clinical guidelines for the use of antiplatelet therapies in patients with ACS who are hospitalized, undergoing percutaneous coronary intervention, or being discharged with maintenance therapy
• Compare and contrast the efficacy and safety of antiplatelet therapies and their use in diverse ACS patients
• Formulate strategies to facilitate transitions of care, improve discharge communication, ensure patient adherence, and reduce complications and hospital readmissions related to ACS
For nurses, case managers:
• Review clinical guidelines for the use of antiplatelet therapies in patients with ACS who are hospitalized, undergoing percutaneous coronary intervention, or being discharged with maintenance therapy
• Explain why specific antiplatelet therapies are selected for specific ACS patient subsets
• Formulate strategies to facilitate transitions of care, improve discharge communication, ensure patient adherence, and reduce complications and hospital readmissions related to ACS
The activity is sponsored by the Academy for Continued Healthcare Learning.
This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC.
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 4.0 or higher and Firefox 3.0 or higher
4. Adobe Flash Player 8.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 4.0 or higher and Firefox 3.0 or higher
4. Adobe Flash Player 8.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
Deepak L. Bhatt, MD, MPH, FACC, FAHA
Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart & Vascular Center
Professor of Medicine, Harvard Medical School
Boston, MA
Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart & Vascular Center
Professor of Medicine, Harvard Medical School
Boston, MA
John Fanikos, RPh, MBA
Adjunct Clinical Professor
Massachusetts College of Pharmacy
Director of Pharmacy
Brigham and Women’s Hospital
Boston, MA
Sheree Schroeder, MSN, RN, RDCS, FASE (Nurse Planner)
Director of Quality Review Services
Accreditation for Cardiovascular Excellence
Washington, DC
Deepak L. Bhatt, MD, MPH (Faculty)
Research Grants: Amarin, AstraZeneca , Bristol-Myers Squibb Company, Eisai, Ethicon, Medtronic, Roche, sanofi-aventis, The Medicines Company
Discussion of Off-Label, Investigational, or Experimental Drug Use: Multiple antithrombotics
Research Grants: Amarin, AstraZeneca , Bristol-Myers Squibb Company, Eisai, Ethicon, Medtronic, Roche, sanofi-aventis, The Medicines Company
Discussion of Off-Label, Investigational, or Experimental Drug Use: Multiple antithrombotics
John Fanikos, RPh, MBA (Faculty)
Consultant: Boehringer-Ingelheim, Inc., Marathon Pharmaceuticals, Inc., Novartis
Discussion of Off-Label, Investigational, or Experimental Drug Use: None
Sheree Schroeder, MSN, RN, RDCS, FASE (Planning Committee)
No relevant financial relationships
Tarra Barot, PhD (Content Reviewer)
No relevant financial relationships
Tarra Barot, PhD (Content Reviewer)
No relevant financial relationships
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
This activity will take approximately 60 minutes to complete. To receive credit, participants are required to complete the pre-test, view the online webcast and complete the post-test and evaluation form. To receive credit, 80% must be achieved on the post-test. A certificate will be immediately available and pharmacist credit will be uploaded to CPE Monitor within 60 days of completion. There is no fee to participate in the activity or for the generation of the certificate.
Physician:
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist:
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity has been approved for a maximum of 1.0 contact hours.
ACPE Universal Activity Number: 0396-0000-14-054-H01-P
Activity Type: Application
Note: CPE credit will be submitted to NABP on the first day of each month.
Nurse:
This continuing nursing education activity was approved by the Ohio Nurses Association (OBN00191),
an accredited approver by the American Nurses Credentialing Center's Commission on
Accreditation.
Case Manager:
This program has been pre-approved by the Commission for Case Manager Certification to provide continuing education credit to Certified Case Managers (CCMs). This course is approved for 1 CE contact hour.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist:
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity has been approved for a maximum of 1.0 contact hours.
ACPE Universal Activity Number: 0396-0000-14-054-H01-P
Activity Type: Application
Note: CPE credit will be submitted to NABP on the first day of each month.
Nurse:
This continuing nursing education activity was approved by the Ohio Nurses Association (OBN00191),
an accredited approver by the American Nurses Credentialing Center's Commission on
Accreditation.
Case Manager:
This program has been pre-approved by the Commission for Case Manager Certification to provide continuing education credit to Certified Case Managers (CCMs). This course is approved for 1 CE contact hour.